Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.15p

Change Today:

-0.60p
52 Week High: 14.25
52 Week Low: 2.40

Currency: UK Pounds
Shares Issued: 500.00m
Volume: 4,318,655

Market Cap: £15.75m
Beta: 0.03

Trade now with Barclays Stockbrokers

Update - Poolbeg Pharma is down today can you capitalise from spread betting? Find out more
Update - Poolbeg Pharma is near the bottom of the FTSE AIM - will it stay here? Have a look at Poolbeg Pharma's chart Find out more
Update - Poolbeg Pharma is a top faller in its sector - can you take advantage with spread betting? Find out more

Poolbeg Pharma Overview

Poolbeg Pharma is a clinical stage infectious disease pharmaceutical company, with a capital light clinical model which the Directors believe enables it to develop multiple products faster and more cost effectively than the traditional biotech model. Poolbeg has aspirations to become the “one-stop shop” for Big Pharma seeking mid-stage products to license or acquire.

Key Personnel

CEO:	Jeremy Skillington
CFO:	Ian O’Connel
Executive Chairman:	Cathal Friel
Independent Non-Executive Director:	Edward Gibson
Independent Non-Executive Director:	Luke O’Neill
Independent Non-Executive Director:	Brendan Buckley
Non-Executive Dir:

Contact Details

Address:	40 Bank Street, Floor 24, London, United Kingdom, E14 5NR
Phone:	+44 (0)20 7183 1499
Website:	http://www.poolbegpharma.com/

Listings

Sector:	Pharma and Biotech(LSE)
Index:	FTSE AIM All-Share
ISIN:	GB00BKPG7Z60

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Poolbeg Pharma Market Data

Currency	UK Pounds
Share Price	3.15p
Change Today	-0.60p
% Change	-16.00 %
52 Week High	14.25
52 Week Low	2.40
Volume	4,318,655
Shares Issued	500.00m
Market Cap	£15.75m
Beta	0.03